Virus-Induced CD8<sup>+</sup> T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
The current battle against Severe Acute Respiratory Syndrome (SARS)-Coronavirus-2 benefits from the worldwide distribution of different vaccine formulations. All anti-SARS-CoV-2 vaccines in use are conceived to induce anti-Spike neutralizing antibodies. However, this strategy still has unresolved is...
Main Author: | Maurizio Federico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/8/922 |
Similar Items
-
Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
by: Flavia Ferrantelli, et al.
Published: (2021-03-01) -
Strong SARS-CoV-2 N-Specific CD8<sup>+</sup> T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
by: Flavia Ferrantelli, et al.
Published: (2022-02-01) -
Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
by: Flavia Ferrantelli, et al.
Published: (2021-05-01) -
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2020-05-01) -
Ageing Curtails the Diversity and Functionality of Nascent CD8<sup>+</sup> T Cell Responses against SARS-CoV-2
by: Davide Proietto, et al.
Published: (2023-01-01)